4//SEC Filing
Litchman Manuel MD 4
Accession 0001104659-20-138581
CIK 0001680048other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:18 PM ET
Size
9.1 KB
Accession
0001104659-20-138581
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Award
COMMON STOCK
2020-08-31$2.48/sh+5,000$12,400→ 493,846 total - Purchase
COMMON STOCK
2020-12-15$2.91/sh+100,000$291,000→ 654,846 total - Award
COMMON STOCK
2020-09-15+61,000→ 554,846 total
Footnotes (4)
- [F1]These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2020 and ending on August 31, 2020 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on February 28, 2020 (the purchase date of the offering period).
- [F2]Includes restricted share units, which vest over various time periods.
- [F3]61,000 shares are restricted share units which vest over various time periods.
- [F4]Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on December 15, 2020, was $2.85 to $2.98. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
MUSTANG BIO, INC.
CIK 0001680048
Entity typeother
Related Parties
1- filerCIK 0001709485
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:18 PM ET
- Size
- 9.1 KB